| [1] |
Yu TM, Lin CL, Chang SN, et al. Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study [J].Mayo Clin Proc, 2014, 89(7):888-895. doi: 10.1016/j.mayocp.2014.02.017
|
| [2] |
Soriano R, Herrera S, Nogués X, et al. Current and future treatments of secondary osteoporosis [J].Best Pract Res Clin Endocrinol Metab, 2014, 28(6):885-894. doi: 10.1016/j.beem.2014.09.004
|
| [3] |
Kalpakcioglu BB, Engelke K, Genant HK. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis [J].Bone, 2011, 48(6):1221-1231. doi: 10.1016/j.bone.2011.02.005
|
| [4] |
Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies [J].Thorax, 2011, 66(8):699-708. doi: 10.1136/thx.2011.160028
|
| [5] |
Hofbauer LC, Rauner M. Minireview: live and let die: molecular effects of glucocorticoids on bone cells [J].Mol Endocrinol, 2009, 23(10):1525-1531. doi: 10.1210/me.2009-0069
|
| [6] |
Saidak Z, Le Henaff C, Azzi S, et al. Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells [J].J Biol Chem, 2015, 290(11):6903-6912. doi: 10.1074/jbc.M114.621219
|
| [7] |
Liou SF, Hsu JH, Chu HC, et al. KMUP-1 Promotes Osteoblast Differentiation Through cAMP and cGMP Pathways and Signaling of BMP-2/Smad1/5/8 and Wnt/β-Catenin [J].J Cell Physiol, 2015, 230(9):2038-2048. doi: 10.1002/jcp.24904
|
| [8] |
Clarke BL. Corticosteroid-induced osteoporosis: an update for dermatologists [J].Am J Clin Dermatol, 2012, 13(3):167-190. doi: 10.2165/11594250-000000000-00000
|
| [9] |
Chen Y, Zheng X, Zou R, et al. Effects of cyclosporin-a on rat skeletal biomechanical properties [J].BMC Musculoskelet Disord, 2011, 12:240. doi: 10.1186/1471-2474-12-240
|
| [10] |
Ponticelli C, Aroldi A. Osteoporosis after organ transplantation [J].Lancet, 2001, 357(9268):1623. doi: 10.1016/S0140-6736(00)04767-X
|
| [11] |
Aroldi A, Tarantino A, Montagnino G, et al. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study [J].Transplantation, 1997, 63(3):380-386. doi: 10.1097/00007890-199702150-00009
|
| [12] |
Monegal A, Navasa M, Guañabens N, et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A [J].Calcif Tissue Int, 2001, 68(2):83-86. doi: 10.1007/BF02678145
|
| [13] |
Luo L, Shi Y, Bai Y, et al. Impact of tacrolimus on bone metabolism after kidney transplantation [J].Int Immunopharmacol, 2012, 13(1):69-72. doi: 10.1016/j.intimp.2012.03.019
|
| [14] |
Westenfeld R, Schlieper G, Wöltje M, et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis: implications for post-transplantation bone disease [J].Nephrol Dial Transplant, 2011, 26(12):4115-4123. doi: 10.1093/ndt/gfr214
|
| [15] |
Alshayeb HM, Josephson MA, Sprague SM. CKD-mineral and bone disorder management in kidney transplant recipients [J].Am J Kidney Dis, 2013, 61(2):310-325. doi: 10.1053/j.ajkd.2012.07.022
|
| [16] |
Pereira S, Pedroso S, Martins L, et al. Bone mineral density after simultaneous kidney-pancreas transplantation: four years follow-up of 57 recipients [J].Transplant Proc, 2010, 42(2):555-557. doi: 10.1016/j.transproceed.2010.01.046
|
| [17] |
Falkiewicz K, Boratyńska M, Zmonarski SC, et al. Evolution of bone disease at 2 years after transplantation: a single-center study [J].Transplant Proc, 2009, 41(8):3063-3066. doi: 10.1016/j.transproceed.2009.09.041
|
| [18] |
Wang TK, O′Sullivan S, Gamble GD, et al. Bone density in heart or lung transplant recipients: a longitudinal study [J].Transplant Proc, 2013, 45(6):2357-2365. doi: 10.1016/j.transproceed.2012.09.117
|
| [19] |
Dolgos S, Hartmann A, Isaksen GA, et al. Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation: a population based study [J].Clin Transplant, 2010, 24(5):E145-E152. doi: 10.1111/ctr.2010.24.issue-5
|
| [20] |
Ebeling PR. Approach to the patient with transplantation-related bone loss [J].J Clin Endocrinol Metab, 2009, 94(5):1483-1490. doi: 10.1210/jc.2009-0205
|
| [21] |
Dalle Carbonare L, Zanatta M, Braga V, et al. Densitometric threshold and vertebral fractures in heart transplant patients [J].Transplantation, 2011, 92(1):106-111. doi: 10.1097/TP.0b013e31821cdeef
|
| [22] |
Hariman A, Alex C, Heroux A, et al. Incidence of fractures after cardiac and lung transplantation: a single center experience [J].J Osteoporos, 2014:573041. https://www.ncbi.nlm.nih.gov/pubmed/24864223
|
| [23] |
Cahill BC, O'Rourke MK, Parker S, et al. Prevention of bone loss and fracture after lung transplantation: a pilot study [J].Transplantation, 2001, 72(7):1251-1255. doi: 10.1097/00007890-200110150-00012
|
| [24] |
Ewers B, Gasbjerg A, Moelgaard C, et al. Vitamin D status in kidney transplant patients: need for intensified routine supplementation [J].Am J Clin Nutr, 2008, 87(2):431-437. https://www.ncbi.nlm.nih.gov/pubmed/18258635
|
| [25] |
Sambrook P, Henderson NK, Keogh A, et al. Effect of calcitriol on bone loss after cardiac or lung transplantation [J].J Bone Miner Res, 2000, 15(9):1818-1824. doi: 10.1359/jbmr.2000.15.9.1818
|
| [26] |
Lan G, Peng L, Xie X, et al. Alendronate is effective to treat bone loss in renal transplantation recipients [J].Transplant Proc, 2008, 40(10):3496-3498. doi: 10.1016/j.transproceed.2008.09.034
|
| [27] |
Wang Z, Han Z, Tao J, et al. Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials [J].PLoS One, 2014, 9(9):e108106. doi: 10.1371/journal.pone.0108106
|
| [28] |
Monegal A, Guañabens N, Suárez MJ, et al. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial [J].Transpl Int, 2009, 22(2):198-206. doi: 10.1111/j.1432-2277.2008.00763.x
|
| [29] |
Wang HH, Chang PC, Chu SH, et al. Osteoporosis after kidney transplantation: preliminary report from a single center [J].Transplant Proc, 2008, 40(7):2412-2413. doi: 10.1016/j.transproceed.2008.06.042
|
| [30] |
Cejka D, Benesch T, Krestan C, et al. Effect of teriparatide on early bone loss after kidney transplantation [J].Am J Transplant, 2008, 8(9):1864-1870. doi: 10.1111/ajt.2008.8.issue-9
|
| [31] |
Isoniemi H, Appelberg J, Nilsson CG, et al. Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. a 2-year follow-up study [J].J Hepatol, 2001, 34(2):299-305. doi: 10.1016/S0168-8278(00)00067-2
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: